The new head of the scientific area at I3PT holds a degree in Biology and a doctorate in Biochemistry and Molecular Biology from the University of Barcelona. Additionally, he has extensive postgraduate training, including a master's in Xenobiotic Evaluation, a master's in Laboratory Animal Science and Welfare from the UAB, and a master's in Senior Management of Healthcare Entities from IESE.
“"It is an exciting challenge and a great responsibility. The Institute has enormous scientific, healthcare, and human potential, and we will work to continue strengthening translational and clinical research, fostering collaboration between hospital and research."
This new leadership also aims to increase the impact and positioning of the I3PT both nationally and internationally. The new director's experience in scientific direction and management of research projects and infrastructures is considered fundamental to strengthening the institute's organizational structure during a phase of growth and consolidation.
With a career spanning over 25 years in biomedical research and innovation, the new director has spent a significant part of his career in leading centers within the Catalan health and research system. For the past nine years, he has served as director of Commercial and Contracted Clinical Research at the Vall d’Hebron Research Institute, where he led a transformation of the clinical research management model.
During this period, he promoted an increase in clinical trial activity and the development of new models of decentralized and patient-centered research. He also participated in strategic European projects and digital transformation initiatives applied to clinical trial management. Previously, he held various leadership positions at the Barcelona Science Park and Vall d'Hebron itself, related to the direction of scientific platforms, management of research infrastructures, and strategic planning of teams and resources.
